Daiichi Sankyo Company, Limited (DSNKY)
OTCMKTS · Delayed Price · Currency is USD
22.16
+0.14 (0.64%)
Dec 17, 2025, 1:21 PM EST
Daiichi Sankyo Company Market Cap
Daiichi Sankyo Company has a market cap or net worth of $41.2 billion as of December 17, 2025. Its market cap has decreased by -24.87% in one year.
Market Cap
41.20B
Enterprise Value
39.01B
Revenue
13.37B
Ranking
n/a
PE Ratio
21.78
Stock Price
$22.16
Market Cap Chart
Since September 28, 2005, Daiichi Sankyo Company's market cap has increased from 2.93B to 41.20B, an increase of 1,308.00%. That is a compound annual growth rate of 13.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 41.20B | -21.01% |
| Dec 30, 2024 | 52.16B | -0.97% |
| Dec 29, 2023 | 52.67B | -14.75% |
| Dec 30, 2022 | 61.78B | 26.88% |
| Dec 30, 2021 | 48.69B | -26.63% |
| Dec 30, 2020 | 66.36B | 54.24% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 841.30M |
| Glass House Brands | 723.84M |
| Elite Pharmaceuticals | 537.17M |
| CytoDyn | 407.36M |
| Northwest Biotherapeutics | 368.73M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 311.74M |
| Nika Pharmaceuticals | 291.10M |